Quantcast

Aircraft Medical Enters Anaesthesia Monitoring Market With Acquisition of Morpheus Medical, S.L.

May 26, 2009

EDINBURGH, Scotland, May 26 /PRNewswire/ — Aircraft Medical (Aircraft),
the UK medical devices company, today announces that it has entered the
emergent Depth of Anaesthesia monitoring market with the acquisition of
Morpheus Medical (Morpheus), the Barcelona-based developer of medical
equipment.

Morpheus is a leading developer of patient monitoring devices for the
anesthesia and critical care markets. Morpheus’ lead product, the IoC-View,
is designed to measure the level of consciousness during general anaesthesia,
helping to avoid the risk of patients remaining conscious through a procedure
or conversely of receiving too much anaesthetic, impeding a fast recovery.

Morpheus’ technology is the first to allow anesthesiologists and critical
care professionals to record levels of brain activity during surgery with
Symbolic Dynamic EEG, via electrodes and wireless transmission. Research
suggests that such monitoring can help reduce the number of patients who
experience consciousness during procedures. In addition, it suggests that
patients whose anaesthesia is guided by neuromonitoring have significantly
better outcomes in terms of quality of recovery and reduction in
post-operative nausea and vomiting.

Morpheus was founded by Erik Webber Jensen, a world renowned researcher
in the area of level of consciousness assessment during general anaesthesia.
Erik has been involved in the development of several anaesthesia monitors
currently on the market. He will stay with the Company in the new position of
Chief Technology Officer of Barcelona group.

The acquisition of Morpheus is in line with Aircraft’s long-term
strategic aim of developing a broader product offering for the anaesthesia
and critical care markets. Morpheus’ expertise in the area of depth of
anaesthesia monitoring devices complements Aircraft’s leadership in
laryngoscopy, with the McGrath(R) Series 5, the world’s first fully portable
video laryngoscope.

Matt McGrath, CEO of Aircraft, said: “The acquisition of Morpheus
provides us with an excellent platform to expand our product offering in the
anaesthesia and critical care markets and is an important step towards
achieving our strategic goal of becoming a global technology leader in these
markets. We will continue to review appropriate license and acquisition
opportunities to achieve this goal, as well as growing our business
organically.”

Erik Webber Jensen, founder of Morpheus, said: “The combination of
Aircraft and Morpheus represents a strong strategic fit for both groups.
Aircraft’s competencies in leading edge design and engineering complement
Morpheus’ portfolio and technology. Bringing these companies together greatly
strengthens the range of products we can offer to anesthesiologists and
critical care specialists.”

Background

Aircraft Medical is the manufacturer of the McGrath(R) Series 5, the
world’s first fully portable video laryngoscope. Its compactness, and a cable
free design, means the life saving benefits of video laryngoscope technology
can fit in the pocket of a paramedic or mobile user. As a result, it is
immediately available for use in potentially life threatening cases. The
McGrath(R) Series 5 is leading the growth of the portable video laryngoscope
market with distribution in North America, Europe and Australasia. Matt
McGrath
, Aircraft Medical’s CEO, was last year named “ Young Scot of the Year”
by the Institute of Contemporary Scotland in recognition of the invention of
McGrath(R) Series 5 and its advancement of healthcare and subsequent
international success.

    Contact:
    Financial Dynamics
    Jonathan Birt: +44(0)207-269-7205
    John Dineen: +44(0)207-269-7205

SOURCE Aircraft Medical


Source: newswire



comments powered by Disqus